Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
HealthTrust Europe (HTE) is seeking to establish a multi-Lot framework agreement for the supply of Radiopharmaceuticals, which are sterile and non-sterile radioactive drugs used in nuclear medicine procedures to diagnose, monitor, and treat diseases.
The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe's discretion.
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| Alliance Medical Radiopharmacy Limited | 04555287 | ~£100,000,000 estimated from lot values | - |
| Curium Pharma UK Ltd | 09347432 | ~£100,000,000 estimated from lot values | - |
| GE Healthcare Limited | 01002610 | ~£100,000,000 estimated from lot values | - |
| Xiel Limited | 11875702 | ~£100,000,000 estimated from lot values | - |
Government spending data: These suppliers have received £19,456,766 in 1,692 payments (over £25k) from The Christie NHS Foundation Trust, Guy's and St Thomas' NHS FT, Manchester University NHS Foundation Trust, United Lincolnshire Hospitals NHS Trust, East Sussex Healthcare NHS Trust and 8 more public bodies (2018-06-18 to 2026-03-31).